We believed that such drug-resistant effect was associated with the stem cell-like properties in OPN overexpressing cells, as oxaliplatin-resistant CRC cells showed higher levels of stem cell markers SOX2 and OCT4 [21, 22]. The gene discussed is SPP1; the disease is colorectal carcinoma.